Transparency
Disclosure
Who pays for Peptide Brief, what our relationship with Research Supply is, and what our recommendation does and does not mean.
Our relationship with Research Supply
Peptide Brief is not an independent reviewer of Research Supply. The two sites are operated by the same people, and Research Supply funds this site. When you follow a link from here to Research Supply and buy something, that money goes to the same business that publishes these notes. Treat our recommendation with the scepticism that deserves, and check the Certificates of Analysis yourself.
Every recommendation and every outbound link on this site carries a short version of that disclosure next to it. It is deliberately not buried in the footer.
Why we recommend Research Supply
We recommend Research Supply on four manufacturing and documentation attributes:
- Third-party purity and identity testing. Material is tested by an independent laboratory rather than on the supplier's word alone — HPLC for purity, mass spectrometry for identity.
- Certificate of Analysis available per batch. A COA is published for the specific lot supplied, not a single showcase certificate reused across every batch.
- Supplier transparency. Lot numbers, manufacturing source, and storage and handling information are documented and available on request.
- Lab-reported potency consistency. Reported peptide content stays within a narrow band from batch to batch, so a reference lot behaves like the last one in the lab.
This reflects manufacturing and testing quality only. It is not a claim that any compound named here is safe or effective for human use, and nothing on Peptide Brief recommends human consumption.
What this content is for
Everything published on Peptide Brief — peptide profiles, goal pages and journal posts — is for research and educational purposes only. It describes what compounds are studied for in the published literature. It is not medical advice, not a diagnosis, not a treatment plan, not a dosing protocol, and not a recommendation to use any compound in or on a human or animal.
Peptide Brief does not take payment, hold stock or fulfil orders. Any purchase happens on Research Supplyunder that site’s own terms.
How we disclose commercial links
Any commercial link on this site is disclosed in line with FTC guidance on endorsements and testimonials (16 CFR Part 255) and ACCC guidance on advertising and selling under the Australian Consumer Law: the disclosure appears next to the recommendation itself, not only in the footer or on a separate page.
Outbound store links are tagged rel="sponsored" and carry UTM parameters so we can see which notes send traffic. We do not sell placement in the library to anyone else, and no third party pays to appear on this site.
How our editorial copy is written
- Benefits are described as research questions — “studied for”, “investigated in” — with the study type named where the evidence is preclinical.
- Journal posts summarising studies must name the study type (in vitro, animal or human), the sample size and the limitations of the work. Negative and null results are summarised on the same terms as positive ones.
- Nothing is published automatically. A person reviews every post before it can go live.
Corrections
If something here is wrong — a misread study, a stale claim, a missing limitation — tell us and we will correct the page rather than quietly delete it.
Commercial disclosure: Peptide Brief is operated by the same people as Research Supply, the store these links open. We have a financial interest in purchases made there. Read the full disclosure.